|
|
| Research article summary (published 29 Nov 2006): |
3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy.
Full Abstract
BACKGROUND: Dementia of Alzheimer type (DAT) has been diagnosed objectively by using single photon emission tomography (SPECT). Donepezil hydrochloride (donepezil) is available for the symptomatic treatment of DAT. In a quantitative evaluation of therapeutic response in DAT, to compare with regional cerebral blood flows (rCBF) of various lesions before and after treatment, uptake in some sorts of cerebral regions of interests (ROIs) were used to be measured. But ROI analysis has problems such as poor reproducibility and lack of objectivity. The aim of this study was to investigate the evaluation of therapeutic response by three-dimensional stereotaxic ROI template (3DSRT), fully automated ROI analysis software, which can objectively estimate rCBF. METHODS: SPECT studies and Alzheimer's Disease Assessment Scale Japan cognitive Subscale function test ADAS-Jcog, as recognitive function test were performed for 22 patients (16 females, 6 males mean age = 73.6 years) who were diagnosed as DAT. On 3DSRT, we compared ratios of the rCBF values of the parietal lobes, temporo-occipital lobes, hippocampus, corpus callosum and the frontal lobes/cerebellar hemispheres before and after medical treatment. To determine a cut-off number of areas exhibiting improved blood flow optimal as an indicator of improvement in cognitive function in response to treatment, receiver operating characteristics (ROC) analysis of number of areas improved blood flow was performed. RESULTS: The number of cases exhibiting changes in cognitive function was greatest when the cut-off number of areas exhibiting improved blood flow was set at 5. CONCLUSIONS: The possibility of evaluation of therapeutic response to Donepezil in patients with DAT using 3DSRT was thus demonstrated by our study.
Author information
Author/s: Higashiyama, Shigeaki (S); Kawabe, Joji (J); Hashimoto, Hiroshi (H); Akiyama, Hisanori (H); Kawamura, Etsushi (E); Torii, Kenji (K); Inoue, Koki (K); Kiriike, Nobuo (N); Shiomi, Susumu (S); Inoue, Yuichi (Y);
Affiliation: Department of Radiology, Osaka City University, Graduate School of Medicine, 1-4-3, Asahimachi, Abeno-ku, Osaka 545-8585, Japan. YQW10673(-atsign-)nifty.ne.jp
Journal and publication information
Publication Type: Journal Article
Journal: Osaka city medical journal (Osaka City Med J), published in Japan. (Language: eng)
Reference: 2006-Dec; vol 52 (issue 2) : pp 55-62
Dates: Created 2007/03/02; Completed 2007/03/20;
PMID: 17330392, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Visual form of Alzheimer's disease and its response to anticholinesterase therapy.
29 Sep 1998 - Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease.
23 Jul 2007 - Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
29 Sep 2001 - Therapeutic standards in Alzheimer disease.
30 Oct 1999 - Donepezil for severe Alzheimer's disease.
27 Jul 2006 - Therapeutic advances: donepezil for the treatment of Alzheimer's disease.
30 Jul 1997 - Is donepezil effective for treating Alzheimer's disease?
30 Mar 1999 - Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebo-controlled studies.
30 Dec 2007 - Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
29 Jun 2001 - Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
30 Jul 2002
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.